羟苯磺酸钙治疗慢性肾脏病致粒细胞缺乏一例
A Case of Agranulocytosis Induced by Chronic Renal Disease Treated with Calcium Dobesilate
DOI: 10.12677/ACM.2021.118489, PDF,   
作者: 钱一苇：济宁医学院临床医学院，山东 济宁；刘 雷*：济宁医学院附属医院肾内科，山东 济宁
关键词: 羟苯磺酸钙；粒细胞缺乏；慢性肾脏病；Calcium Dobesilate； Agranulocytosis； Chronic Kidney Disease
摘要: 本文报道一例服用羟苯磺酸钙后出现粒细胞缺乏(agranulocytosis)的案例。患者，女，37岁，临床表现为慢性肾脏病和粒细胞缺乏，完善相关检查排除其他诱因，考虑粒缺与服用羟苯磺酸钙有关。给予升白细胞、抗感染等治疗后，粒细胞恢复至正常。
Abstract: We report a case of granulocytosis after taking calcium hydroxybenzosulfonate. The patient, a 37-year-old female, presented with chronic nephropathy and granulocytosis, perform relevant tests to exclude other causes, and consider that the agranulocytosis is related to the use of calcium hydroxybenzosulfonate. After treated with leukocyte increase and anti-infection, the patient’s granulocytes returned to normal.
文章引用：钱一苇, 刘雷. 羟苯磺酸钙治疗慢性肾脏病致粒细胞缺乏一例[J]. 临床医学进展, 2021, 11(8): 3373-3377. https://doi.org/10.12677/ACM.2021.118489

参考文献

[1] Curtis, B.R. (2014) Drug-Induced Immune Neutropenia/Agranulocytosis. Immunohematology, 30, 95-101. [Google Scholar] [CrossRef] 
[2] Andres, E. and Maloisel, F. (2008) Idiosyncratic Drug-Induced Agranulocytosis or Acute Neutropenia. Current Opinion in Hematology, 15, 15-21. [Google Scholar] [CrossRef] 
[3] Andres, E. and Mourot-Cottet, R. (2017) Non-Chemotherapy Drug-Induced Neutropenia—An Update. Expert Opinion on Drug Safety, 16, 1235-1242. [Google Scholar] [CrossRef] [PubMed]
[4] Lorenzo-Villalba, N., et al. (2020) Idiosyncratic Drug-Induced Neutropenia and Agranulocytosis in Elderly Patients. Journal of Clinical Medicine, 9, 1808. [Google Scholar] [CrossRef] [PubMed]
[5] Keller, O. and Mourot, R. (2014) Drug-Induced Agranulocytosis in Elderly Patients: Diagnosis and Management of Life-Threatening Infections and Septic Shock. Journal of Infectious Diseases & Therapy, 2, 191. [Google Scholar] [CrossRef] 
[6] 张成珍, 张玉侠. 羟苯磺酸钙的应用进展[J]. 医药导报, 2012, 31(9): 1181-1184.
[7] Liu, J., Li, S. and Sun, D. (2019) Calcium Dobesilate and Micro-Vascular Diseases. Life Sciences, 221, 348-353. [Google Scholar] [CrossRef] [PubMed]
[8] Wang, Y., Zuo, B., Wang, N., Li, S., Liu, C. and Sun, D. (2020) Calcium Dobesilate Mediates Renal Interstitial Fibrosis and Delay Renal Peritubular Capillary Loss through Sirt1/p53 Signaling Pathway. Biomedicine & Pharmacotherapy, 132, Article ID: 110798. [Google Scholar] [CrossRef] [PubMed]
[9] 赵霞, 张玉侠. 改善肾脏微循环延缓肾纤维化的研究进展[J]. 中国中西医结合肾病杂志, 2008, 9(11): 1031-1033.
[10] 刘晓城, 吕永蔓, 金晓冰, 曾红兵, 高虹宇. 羟苯磺酸钙治疗慢性肾功能不全的临床观察[J]. 中华医学杂志, 2004, 84(22): 48-49.
[11] 郭伟, 冯江敏, 李小姝. 羟苯磺酸钙治疗慢性马兜铃酸肾病实验研究和临床观察[J]. 当代医学, 2009, 15(6): 114-115.
[12] 王雪春, 刘先英, 刘玲. 羟苯磺酸钙对高血压早期肾损害的影响[J]. 中国医药导报, 2016, 13(1): 1126-129.
[13] 叶小珍, 卢斌, 彭丽, 杜宏, 邵加庆. 羟苯磺酸钙治疗糖尿病视网膜病变患者致粒细胞缺乏一例[J]. 中华内分泌代谢杂志, 2017, 33(2): 145-146.
[14] Ibañez, L., Ballarin, E., Vidal, X. and Laporte, J.R. (2000) Agranulocytosis Associated with Calcium Dobesilate Clinical Course and Risk Estimation with the Case-Control and the Case-Population Approaches. European Journal of Clinical Pharmacology, 56, 763-767. [Google Scholar] [CrossRef] [PubMed]
[15] Zapater, P., Horga, J.F. and Garcia, A. (2003) Risk of Drug-Induced Agranulocytosis: The Case of Calcium Dobesilate. European Journal of Clinical Pharmacology, 58, 767-772. [Google Scholar] [CrossRef] [PubMed]

为你推荐